✦ LIBER ✦

DU3 Market Access Delays for CNS Drugs in Europe

✍ Scribed by S.J.A. Flostrand; L. Anderson; G. Esposito

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PHP32 Market Access Variation for Lifest

✍ A.W. Bastian; S. Gea-Sanchez; M. Tangari 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

PCN139 OPTIMISING MARKET ACCESS FOR ONCO

✍ H Dummett; B Shankland 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PHP19 REGIONAL MARKET ACCESS IN EQUALITI

✍ A Vieta; E Gimenez; X Badia 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PRM24 Scan: An Integrated System for Mar

✍ Lanati, E.P.; Lidonnici, D.; D'Ausilio, A.; Iorio, A.; Jommi, C. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PHP132 Time to Market Access for Innovat

✍ J. Maervoet; M. Toumi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Market Access of Cancer Drugs in Europea

✍ Pauwels, K.; Huys, I.; De Nys, K.; Casteels, M.R.; Simoens, S. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB